−2.97CNY
−294.16 MCNY
About HINOVA PHARMACEUTICALS INC.
Sector
CEO
Yuan Wei Chen
Headquarters
Chengdu
Website
Employees (FY)
181
Founded
2013
ISIN
CNE1000059F5
FIGI
BBG0115TJ3S0
Hinova Pharmaceuticals, Inc. engages in the research and development of pharmaceutical products. It offers castration-resistant prostate cancer treatment and anti-gout and hyperuricemia drugs. The company was founded by Yuan Wei Chen and Xing Hai Li on February 5, 2013 and is headquartered in Chengdu, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 688302 is 29.08 CNY — it has decreased by 0.92% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange HINOVA PHARMACEUTICALS INC. stocks are traded under the ticker 688302.
688302 stock is 2.79% volatile and has beta coefficient of 1.19. Check out the list of the most volatile stocks — is HINOVA PHARMACEUTICALS INC. there?
Yes, you can track HINOVA PHARMACEUTICALS INC. financials in yearly and quarterly reports right on TradingView.
688302 stock has risen by 15.90% compared to the previous week, the month change is a 10.47% fall, over the last year HINOVA PHARMACEUTICALS INC. has showed a 59.33% decrease.
688302 net income for the last quarter is −47.21 M CNY, while the quarter before that showed −56.11 M CNY of net income which accounts for 15.86% change. Track more HINOVA PHARMACEUTICALS INC. financial stats to get the full picture.
No, 688302 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 688302 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HINOVA PHARMACEUTICALS INC. stock right from TradingView charts — choose your broker and connect to your account.
As of May 1, 2024, the company has 181.00 employees. See our rating of the largest employees — is HINOVA PHARMACEUTICALS INC. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HINOVA PHARMACEUTICALS INC. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HINOVA PHARMACEUTICALS INC. stock shows the sell signal. See more of HINOVA PHARMACEUTICALS INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.